Melanie Maytin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Melanie Maytin has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Laurence M. Epstein
Brigham and Women's Hospital, Boston, Massachusetts
7 shared publicationsRoy M. John
Brigham and Women's Hospital, Boston, Massachusetts
4 shared publicationsRoger G. Carrillo
University of Miami Miller School of Medicine, Miami, Florida
3 shared publicationsAvi Fischer
Mount Sinai School of Medicine, New York, New York
2 shared publicationsCharles A. Henrikson
Oregon Health & Science University, Portland, Oregon
2 shared publicationsCharles J. Love
Ohio State University Medical Center, Columbus, Ohio
2 shared publications
Latest Publications
- 3 December 2015
- Published by MediaSphere Medical LLC in Journal of Innovations in Cardiac Rhythm Management
- Vol. 6 (11)
Device Pocket Scar Predicts Transvenous Lead Extraction Difficulty
Device Pocket Scar Predicts Transvenous Lead Extraction Difficulty
- 3 December 2015
- Published by MediaSphere Medical LLC in Journal of Innovations in Cardiac Rhythm Management
- Vol. 6 (11)
Device Pocket Scar Predicts Transvenous Lead Extraction Difficulty
Device Pocket Scar Predicts Transvenous Lead Extraction Difficulty
- 29 April 2015
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 17 (6) , 1-7
ICD and CRT Use in Ischemic Heart Disease in Women
Although the role of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy (CRT) in improving outcomes in ischemic cardiomyopathy (ICM) has been described, the data regarding gender-based survival outcomes are limited. There is a higher preponderance of non-ischemic cardiomyopathy (NICM) in women, and most of the ICM literature is derived from sub-study analysis. This review summarizes the current body of literature on prognosis, pathophysiology, and the present clinical practice for device implantation in women with ICM.
- 29 April 2015
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 17 (6) , 1-7
ICD and CRT Use in Ischemic Heart Disease in Women
Although the role of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy (CRT) in improving outcomes in ischemic cardiomyopathy (ICM) has been described, the data regarding gender-based survival outcomes are limited. There is a higher preponderance of non-ischemic cardiomyopathy (NICM) in women, and most of the ICM literature is derived from sub-study analysis. This review summarizes the current body of literature on prognosis, pathophysiology, and the present clinical practice for device implantation in women with ICM.
- 12 December 2014
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 38 (3) , 319-325
Virtual Reality Lead Extraction as a Method for Training New Physicians: A Pilot Study
Background: It is estimated that the demand for transvenous lead extraction (TLE) has reached an annual extraction rate of nearly 24,000 patients worldwide. Despite technologic advances, TLE still has the potential for significant morbidity and mortality. Complication rates with TLE directly parallel operator experience. However, obtaining adequate training during and postfellowship can be difficult. Given the potential for catastrophic complications and the steep learning curve (up to 300 cases) associated with this procedure, we sought to validate a virtual reality (VR) lead extraction simulator as an innovative training and evaluation tool for physicians new to TLE.Methods: We randomized eight electrophysiology fellows to VR simulator versus conventional training. We compared procedural skill competency between the groups using simulator competency, tactile measurements, markers of proficiency and attitudes, and cognitive abilities battery.Results: Practical skills and simulator complications differed significantly between the VR simulator and conventional training groups. The VR simulator group executed patient preparation and procedure performance better than the conventional group (P < 0.01). All four fellows randomized to conventional training experienced a simulator complication (two superior vena cava [SVC] tears, three right ventricle [RV] avulsions) versus one fellow in the VR simulator group (one SVC tear) (P = 0.02). Tactile measurements revealed a trend toward excess pushing versus pulling forces among the conventionally trained group. The time for lead removal was also significantly higher in the conventional training group (12.46 minutes vs 5.54 minutes, P = 0.02). There was no significant difference in baseline or posttraining cognitive ability.Conclusions: We contend that the implementation of alternative training tools such as a VR simulation model will improve physician training and allow for an innovative pathway to assess the achievement of competency.
- 12 December 2014
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 38 (3) , 319-325
Virtual Reality Lead Extraction as a Method for Training New Physicians: A Pilot Study
Background: It is estimated that the demand for transvenous lead extraction (TLE) has reached an annual extraction rate of nearly 24,000 patients worldwide. Despite technologic advances, TLE still has the potential for significant morbidity and mortality. Complication rates with TLE directly parallel operator experience. However, obtaining adequate training during and postfellowship can be difficult. Given the potential for catastrophic complications and the steep learning curve (up to 300 cases) associated with this procedure, we sought to validate a virtual reality (VR) lead extraction simulator as an innovative training and evaluation tool for physicians new to TLE.Methods: We randomized eight electrophysiology fellows to VR simulator versus conventional training. We compared procedural skill competency between the groups using simulator competency, tactile measurements, markers of proficiency and attitudes, and cognitive abilities battery.Results: Practical skills and simulator complications differed significantly between the VR simulator and conventional training groups. The VR simulator group executed patient preparation and procedure performance better than the conventional group (P < 0.01). All four fellows randomized to conventional training experienced a simulator complication (two superior vena cava [SVC] tears, three right ventricle [RV] avulsions) versus one fellow in the VR simulator group (one SVC tear) (P = 0.02). Tactile measurements revealed a trend toward excess pushing versus pulling forces among the conventionally trained group. The time for lead removal was also significantly higher in the conventional training group (12.46 minutes vs 5.54 minutes, P = 0.02). There was no significant difference in baseline or posttraining cognitive ability.Conclusions: We contend that the implementation of alternative training tools such as a VR simulation model will improve physician training and allow for an innovative pathway to assess the achievement of competency.
- 1 September 2014
- Published by Elsevier in Heart Rhythm
- Vol. 11 (9) , 1613-1618
Multicenter experience with extraction of the Riata/Riata ST ICD lead
- 1 September 2014
- Published by Elsevier in Heart Rhythm
- Vol. 11 (9) , 1613-1618
Multicenter experience with extraction of the Riata/Riata ST ICD lead
- 20 June 2013
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 36 (10) , 1280-1283
Multicenter Experience with Transvenous Lead Extraction in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is becoming a more commonly diagnosed entity with frequent need for coincident implantable cardioverter defibrillator (ICD) therapy. Given predominant right ventricular disease with thinning of the wall, there is concern regarding the safety of transvenous lead extraction (TLE) in ARVC.Methods: We performed a retrospective study of consecutive patients with ARVC undergoing TLE of ICD leads at three high‐volume centers. Patient and lead characteristics, indications, outcomes, and extraction sheath (ES) use were analyzed.Results: Between 1999 and 2012, more than 2,000 lead extractions were performed at the three centers. Of these, 11 patients underwent 14 extractions meeting inclusion criteria. Mean implant duration was 74.5 months (range 6–140). In 11 patients, a total of 22 leads (16 high‐voltage and six pace‐sense leads) were extracted in 14 procedures. The cohort was 50% male with a mean age of 45 years (range, 25–56) and mean ejection fraction 55 ± 13%. The majority (64%) of leads were extracted due to lead malfunction, three patients had an ICD lead removed for exit block, and three patients underwent TLE for infectious complications (two local, one systemic). ES assistance with laser or mechanical cutting sheaths was employed in the vast majority of cases (85.7%). All leads were removed completely. There were no major procedural complications. In five cases, lead reimplantation encountered low‐amplitude R waves requiring multiple attempted lead positions before final successful implant.Conclusions: This is the first reported series of TLE in ARVC patients. TLE can be performed safely and effectively in patients with ARVC by experienced operators at high‐volume centers with a low complication rate.
- 20 June 2013
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 36 (10) , 1280-1283
Multicenter Experience with Transvenous Lead Extraction in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is becoming a more commonly diagnosed entity with frequent need for coincident implantable cardioverter defibrillator (ICD) therapy. Given predominant right ventricular disease with thinning of the wall, there is concern regarding the safety of transvenous lead extraction (TLE) in ARVC.Methods: We performed a retrospective study of consecutive patients with ARVC undergoing TLE of ICD leads at three high‐volume centers. Patient and lead characteristics, indications, outcomes, and extraction sheath (ES) use were analyzed.Results: Between 1999 and 2012, more than 2,000 lead extractions were performed at the three centers. Of these, 11 patients underwent 14 extractions meeting inclusion criteria. Mean implant duration was 74.5 months (range 6–140). In 11 patients, a total of 22 leads (16 high‐voltage and six pace‐sense leads) were extracted in 14 procedures. The cohort was 50% male with a mean age of 45 years (range, 25–56) and mean ejection fraction 55 ± 13%. The majority (64%) of leads were extracted due to lead malfunction, three patients had an ICD lead removed for exit block, and three patients underwent TLE for infectious complications (two local, one systemic). ES assistance with laser or mechanical cutting sheaths was employed in the vast majority of cases (85.7%). All leads were removed completely. There were no major procedural complications. In five cases, lead reimplantation encountered low‐amplitude R waves requiring multiple attempted lead positions before final successful implant.Conclusions: This is the first reported series of TLE in ARVC patients. TLE can be performed safely and effectively in patients with ARVC by experienced operators at high‐volume centers with a low complication rate.
- 1 September 2012
- Published by Elsevier in Heart Rhythm
- Vol. 9 (9) , 1446-1451
Lead electrical parameters may not predict integrity of the Sprint Fidelis ICD lead
- 1 September 2012
- Published by Elsevier in Heart Rhythm
- Vol. 9 (9) , 1446-1451
Lead electrical parameters may not predict integrity of the Sprint Fidelis ICD lead
- 1 April 2012
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 5 (2) , 252-257
Long-Term Mortality After Transvenous Lead Extraction
Background—: The number of cardiovascular implantable electronic devices has increased progressively and has led to an increased need for transvenous lead extraction (TLE). Multiple reports of TLE procedural outcomes exist; however, data regarding postprocedural and long-term mortality are limited. Methods and Results—: We performed a retrospective study of consecutive patients undergoing TLE at a single, high-volume center. Patient characteristics, indications, and outcomes were analyzed. A multivariable Cox regression model was developed to identify factors associated with mortality. Between January 2000 and December 2010, 985 patients underwent 1043 TLE procedures. The cohort was 68% male, with a mean age of 63 years (range, 15–95 years) and a left ventricular ejection fraction of 40±17%. Indications included systemic infection (18%), pocket infection (32%), lead malfunction (30%), and other (device upgrade, venous occlusion, and advisory leads; 20%). There were no procedure-related deaths. The mean follow-up was 3.7 years (range, 0.1–11.3 years). Kaplan–Meier analysis demonstrated a cumulative mortality of 2.1% at 30 days, 4.2% at 3 months, 8.4% at 1 year, and 46.8% at 10 years. In multivariable analysis, systemic infection (hazard ratio [HR], 3.52; 95% CI, 1.95–6.38; P P =0.0004), device system upgrade (HR, 2.14; 95% CI, 1.07–4.25; P =0.03; indication compared with a reference group of extraction for lead malfunction), diabetes mellitus (HR, 1.71; 95% CI, 1.25–2.35; P =0.0009), increasing age (HR, 1.05; 95% CI, 1.04–1.07; P P =0.04) were significant correlates of increased mortality risk. Conclusions—: Although TLE procedural mortality is exceedingly low at high-volume centers, postprocedural and long-term mortality remain high in certain patient populations, such as elderly patients and those undergoing TLE for infectious indications and device system upgrade. Information regarding TLE long-term outcomes may help guide cardiovascular implantable electronic device and lead management.
- 1 April 2012
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 5 (2) , 252-257
Long-Term Mortality After Transvenous Lead Extraction
Background—: The number of cardiovascular implantable electronic devices has increased progressively and has led to an increased need for transvenous lead extraction (TLE). Multiple reports of TLE procedural outcomes exist; however, data regarding postprocedural and long-term mortality are limited. Methods and Results—: We performed a retrospective study of consecutive patients undergoing TLE at a single, high-volume center. Patient characteristics, indications, and outcomes were analyzed. A multivariable Cox regression model was developed to identify factors associated with mortality. Between January 2000 and December 2010, 985 patients underwent 1043 TLE procedures. The cohort was 68% male, with a mean age of 63 years (range, 15–95 years) and a left ventricular ejection fraction of 40±17%. Indications included systemic infection (18%), pocket infection (32%), lead malfunction (30%), and other (device upgrade, venous occlusion, and advisory leads; 20%). There were no procedure-related deaths. The mean follow-up was 3.7 years (range, 0.1–11.3 years). Kaplan–Meier analysis demonstrated a cumulative mortality of 2.1% at 30 days, 4.2% at 3 months, 8.4% at 1 year, and 46.8% at 10 years. In multivariable analysis, systemic infection (hazard ratio [HR], 3.52; 95% CI, 1.95–6.38; P P =0.0004), device system upgrade (HR, 2.14; 95% CI, 1.07–4.25; P =0.03; indication compared with a reference group of extraction for lead malfunction), diabetes mellitus (HR, 1.71; 95% CI, 1.25–2.35; P =0.0009), increasing age (HR, 1.05; 95% CI, 1.04–1.07; P P =0.04) were significant correlates of increased mortality risk. Conclusions—: Although TLE procedural mortality is exceedingly low at high-volume centers, postprocedural and long-term mortality remain high in certain patient populations, such as elderly patients and those undergoing TLE for infectious indications and device system upgrade. Information regarding TLE long-term outcomes may help guide cardiovascular implantable electronic device and lead management.
- 20 March 2012
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 35 (6) , 641-647
Multicenter Experience with Transvenous Lead Extraction of Active Fixation Coronary Sinus Leads
Active fixation coronary sinus (CS) leads limit dislodgement and represent an attractive option to the implanter. Although extraction of passive fixation CS leads is a common and frequently uncomplicated procedure, data regarding extraction of chronically implanted active fixation CS leads are limited. We performed a retrospective cohort study of patients undergoing active fixation CS lead extraction at six centers. Patient and procedural characteristics, indications for extraction, use of extraction sheath (ES) assistance, and outcomes are reported. Between January 2009 and February 2011, 12 patients underwent transvenous lead extraction (TLE) of Medtronic StarFix® lead (Medtronic Inc., Minneapolis, MN, USA). The cohort was 83% male with mean age 71 ± 14 years. Average implant duration was 14.2 ± 5.7 months (2.3-23.6). All leads but one were removed for infectious indications (67% systemic infection). At the time of explant, the fixation lobes were completely retracted in only one of the 12 cases and ES assistance was required for lead removal in all cases (58% laser, 25% cutting, 25% mechanical, and 25% femoral). The majority of cases required advancement of the sheath into the CS (75.0%) and often into a branch vessel (41.7%). One lead could not be removed transvenously and required surgical lead extraction. There were no major complications. Examination of the leads after extraction frequently revealed significant tissue growth into the fixation lobes. Although TLE of active fixation CS leads can be a safe procedure in select patients and experienced hands, powered sheaths and aggressive techniques are frequently required for successful removal despite relatively short implant durations. This raises significant concern regarding future TLE of active fixation CS leads with longer implant durations.
- 20 March 2012
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 35 (6) , 641-647
Multicenter Experience with Transvenous Lead Extraction of Active Fixation Coronary Sinus Leads
Active fixation coronary sinus (CS) leads limit dislodgement and represent an attractive option to the implanter. Although extraction of passive fixation CS leads is a common and frequently uncomplicated procedure, data regarding extraction of chronically implanted active fixation CS leads are limited. We performed a retrospective cohort study of patients undergoing active fixation CS lead extraction at six centers. Patient and procedural characteristics, indications for extraction, use of extraction sheath (ES) assistance, and outcomes are reported. Between January 2009 and February 2011, 12 patients underwent transvenous lead extraction (TLE) of Medtronic StarFix® lead (Medtronic Inc., Minneapolis, MN, USA). The cohort was 83% male with mean age 71 ± 14 years. Average implant duration was 14.2 ± 5.7 months (2.3-23.6). All leads but one were removed for infectious indications (67% systemic infection). At the time of explant, the fixation lobes were completely retracted in only one of the 12 cases and ES assistance was required for lead removal in all cases (58% laser, 25% cutting, 25% mechanical, and 25% femoral). The majority of cases required advancement of the sheath into the CS (75.0%) and often into a branch vessel (41.7%). One lead could not be removed transvenously and required surgical lead extraction. There were no major complications. Examination of the leads after extraction frequently revealed significant tissue growth into the fixation lobes. Although TLE of active fixation CS leads can be a safe procedure in select patients and experienced hands, powered sheaths and aggressive techniques are frequently required for successful removal despite relatively short implant durations. This raises significant concern regarding future TLE of active fixation CS leads with longer implant durations.
- 31 December 2011
- Published by Elsevier in Cardiac Electrophysiology Clinics
- Vol. 3 (4) , 663-673
Should Every Broken Lead Be Extracted?
- 31 December 2011
- Published by Elsevier in Cardiac Electrophysiology Clinics
- Vol. 3 (4) , 663-673
Should Every Broken Lead Be Extracted?
- 20 October 2011
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 34 (12) , 1615-1620
Lead Implant Duration Does Not Always Predict Ease of Extraction: Extraction Sheath May Be Required at < 1 Year
Introduction: Lead implant duration is a predictor of extraction sheath (ES) use in transvenous lead extraction (TLE). Most operators agree that leads with short implant durations can be extracted easily but data regarding defibrillator (implantable cardioverter‐defibrillator [ICD]) leads and newer generation leads with backfilled coils are limited. Methods and Results: We performed a retrospective study of consecutive patients undergoing TLE of leads with implant durations of ≤ 2 years at a single, high‐volume center. Patient and lead characteristics, indications, and ES use were analyzed. Between January 2000 and January 2011, 139 patients underwent TLE meeting inclusion criteria. Mean implant duration was 13.2 ± 6.4 months. The cohort was 67% male with a mean age of 63 years (16–93) and left ventricular ejection fraction of 36 ± 17%. Indications for extraction included infection (51%), lead malfunction (27%), device upgrade (13%), and other indications (venous occlusion, severe chronic pain at site of device or lead, advisory leads, etc., 9%). Extraction was achieved with simple traction alone in 68% of the 239 leads removed. ES assistance with laser or femoral sheaths was employed in 32% of cases. ES use increased significantly with longer implant duration (P = 0.0004). In multivariate analysis, young age, the presence of an ICD, and increasing implant duration were the strongest predictors of the need for ES assistance for successful lead removal. There was no statistically significant difference in ES use between older and newer generation ICD leads (P = 0.68). Conclusions: While leads with short implant durations may be extracted easily, the need for ES assistance is significant and frequently unpredictable even with newer generation ICD leads. Thus, operators should be fully prepared to use all available methods of extraction in every case regardless of implant duration. (PACE 2011; 34:1615–1620)
- 20 October 2011
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 34 (12) , 1615-1620
Lead Implant Duration Does Not Always Predict Ease of Extraction: Extraction Sheath May Be Required at < 1 Year
Introduction: Lead implant duration is a predictor of extraction sheath (ES) use in transvenous lead extraction (TLE). Most operators agree that leads with short implant durations can be extracted easily but data regarding defibrillator (implantable cardioverter‐defibrillator [ICD]) leads and newer generation leads with backfilled coils are limited. Methods and Results: We performed a retrospective study of consecutive patients undergoing TLE of leads with implant durations of ≤ 2 years at a single, high‐volume center. Patient and lead characteristics, indications, and ES use were analyzed. Between January 2000 and January 2011, 139 patients underwent TLE meeting inclusion criteria. Mean implant duration was 13.2 ± 6.4 months. The cohort was 67% male with a mean age of 63 years (16–93) and left ventricular ejection fraction of 36 ± 17%. Indications for extraction included infection (51%), lead malfunction (27%), device upgrade (13%), and other indications (venous occlusion, severe chronic pain at site of device or lead, advisory leads, etc., 9%). Extraction was achieved with simple traction alone in 68% of the 239 leads removed. ES assistance with laser or femoral sheaths was employed in 32% of cases. ES use increased significantly with longer implant duration (P = 0.0004). In multivariate analysis, young age, the presence of an ICD, and increasing implant duration were the strongest predictors of the need for ES assistance for successful lead removal. There was no statistically significant difference in ES use between older and newer generation ICD leads (P = 0.68). Conclusions: While leads with short implant durations may be extracted easily, the need for ES assistance is significant and frequently unpredictable even with newer generation ICD leads. Thus, operators should be fully prepared to use all available methods of extraction in every case regardless of implant duration. (PACE 2011; 34:1615–1620)